UCB (EBR:UCB) UCB Media Room - Share Repurchase Program 2023 to cover UCB's Long Term Incentive Plans for employees
Directive transparence : information réglementée Communiqué sur comptes, résultats, chiffres d’affaires
24/02/2023 20:01
https://mb.cision.com/Public/18595/3723316/8f47bd4e67b70fd9_800x800ar.png
** Share Repurchase Program 2023 to cover UCB's Long Term Incentive Plans f=
or employees
------------------------------------------------------------
Brussels (Belgium), 24 February 2023 =E2=80=93 20:00 (CET) =E2=80=93 Regula=
ted information
In application of article 7:215 of the Belgian Code of Companies and Associ=
ations, UCB=C2=A0SA/NV (=E2=80=9CUCB=E2=80=9D or the =E2=80=9CCompany=E2=80=
=9D) (Euronext Brussels: UCB) announces the launch of a share buy-back prog=
ram (the =E2=80=9CShare Repurchase Program 2023=E2=80=9D), effective as of =
27 February 2023.
The repurchase of UCB shares under this program intends to cover current an=
d future obligations under UCB's Long Term Incentive Plans for its employee=
s. UCB will continuously monitor both its current and future obligations un=
der such plans in view of keeping an adequate level of treasury shares.
Under this program, UCB may acquire from time to time its common stock, for=
a maximum of 500 000 UCB shares. The share repurchases will be conducted u=
nder the terms and conditions approved by the extraordinary general shareho=
lders=E2=80=99 meeting of the Company held on 28 April 2022. The timing of =
the repurchase of shares pursuant to the program will depend on a variety o=
f factors, including market conditions. The Share Repurchase Program may be=
suspended or discontinued at any time.
UCB has requested a financial intermediary to repurchase UCB shares on its =
behalf under the terms of a mandate agreement with initial validity until t=
he earlier of 28 April 2023 or the mandate having been completed.
During the Share Repurchase Program 2023, regular updates will be published=
in accordance with applicable legislation.
In the framework of UCB=E2=80=99s ongoing cash and treasury shares manageme=
nt, UCB may decide to enter into equity swap transactions, including during=
the term of this Share Repurchase Program 2023. Any such transaction will =
be reported in accordance with applicable legislation.
This press release is available on UCB=C2=A0SA/NV=E2=80=99s website via the=
following link. (https://www.ucb.com/stories-media/Press-Releases)
For further information, contact UCB:
Investor Relations
Antje Witte
T +32 2 559 94 14
antje.witte@ucb.com (mailto:antje.witte@ucb.com)
Corporate Communications
Laurent Schots
T+32 2 559 92 64
laurent.schots@ucb.com (mailto:laurent.schots@ucb.com) =C2=A0=C2=A0=C2=A0=
=C2=A0=C2=A0
About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With approximately 8 700 peopl=
e in 36 countries, the company generated revenue of =E2=82=AC 5.5 billion i=
n 2022. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit=
ter: @UCB_news
GenericFile
230224 - PR Share Repurchase Program 2023 - ENG Final (https://mb.cision.co=
m/Public/18595/3723316/b2bc5da96c1e2f24.pdf) GenericFile
230224 - PR UCB Aandelen Inkoop Programma 2023 - NL Final (https://mb.cisio=
n.com/Public/18595/3723316/802fb623f76f9dce.pdf) GenericFile
230224 - PR UCB Programme de rachat d actions propres 2023 -FR Final (https=
://mb.cision.com/Public/18595/3723316/b104ad20eb310597.pdf)
______________________
If you would rather not receive future communications from UCB SA, please g=
o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x129811x1x6868579x2400=
0x6&Email=3Dregnews%40symexglobal.com.
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium
26/04/2024 20:00
25/04/2024 18:00
25/04/2024 07:01
23/04/2024 20:00
22/04/2024 07:01
19/04/2024 20:00
17/04/2024 07:01
12/04/2024 20:00
12/04/2024 18:01
12/04/2024 07:01